Upgrade to SI Premium - Free Trial

Edwards Lifesciences (EW) PT Raised to $174 at Canaccord Genuity

February 2, 2018 7:08 AM
Canaccord Genuity raised its price target on Edwards Lifesciences (NYSE: EW) to $174.00 (from $140.00) while maintaining a Buy rating ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles